MedTrace Logo

Multimodal Analgesia in Laparoscopic Radical Gastrectomy With Gastric Cancer: a Multi-center Study

NCT03236051 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2017-08-01

No results posted yet for this study

Summary

The study is aimed to explore the effects of multimodal analgesia consisting of ropivacaine's wound infiltration, parecoxib's intravenous injection and oxycodone-acetaminophen tablets' oral administration on postoperative pain and rehabilitation after laparoscopic radical gastrectomy for patients with gastric cancer.

Conditions

Interventions

PROCEDURE

Multimodal analgesia

Multimodal analgesia is the name of a procedure or program. Multimodal analgesia doesn't mean different interventions are used. Patients in this group need receive this analgesia program (procedure) instead of one analgesic drug or technology. The program consists of incision infiltration with ropivacaine, intravenous injection of parecoxib, and oral administration of oxycodone/paracetamol mixture.

PROCEDURE

PCIA analgesia

PCIA analgesia:patient-controlled intravenous analgesia with tramadol.

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • JIANG Zhi-Wei

    lead OTHER

Principal Investigators

  • Zhi-Wei JIANG, Ph.D. · Jinling Hospital, Medical School of Nanjing University

  • Jian ZHAO, Ph.D. · Jinling Hospital, Medical School of Nanjing University

  • Gang WANG, Ph.D. · Jinling Hospital, Medical School of Nanjing University

  • Jiang LIU, M.D. · Jinling Hospital, Medical School of Nanjing University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-10
Primary Completion
2018-06-30
Completion
2018-08-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03236051 on ClinicalTrials.gov